ValuEngine Downgrades LHC Group (LHCG) to Hold

ValuEngine cut shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a research note published on Friday morning.

Several other equities research analysts also recently weighed in on the company. SunTrust Banks restated a buy rating and set a $75.00 price target on shares of LHC Group in a report on Friday, November 3rd. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $79.00 price target on the stock in a report on Wednesday, November 8th. Craig Hallum restated a buy rating and set a $80.00 price target (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Jefferies Group upped their price target on LHC Group from $68.00 to $83.00 and gave the stock a buy rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Robert W. Baird restated a hold rating and set a $63.00 price target on shares of LHC Group in a report on Tuesday, September 12th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $77.10.

Shares of LHC Group (NASDAQ LHCG) opened at $64.86 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $1,196.00, a price-to-earnings ratio of 28.08, a P/E/G ratio of 1.94 and a beta of 0.69. LHC Group has a 1-year low of $41.66 and a 1-year high of $76.14.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.04. The firm had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The company’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.54 EPS. research analysts forecast that LHC Group will post 2.4 earnings per share for the current fiscal year.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.

Several large investors have recently added to or reduced their stakes in LHCG. Nine Chapters Capital Management LLC acquired a new stake in shares of LHC Group in the 3rd quarter valued at about $255,000. Bessemer Group Inc. boosted its position in shares of LHC Group by 17.2% in the 3rd quarter. Bessemer Group Inc. now owns 20,400 shares of the health services provider’s stock valued at $1,447,000 after purchasing an additional 3,000 shares during the period. Smith Asset Management Group LP acquired a new stake in shares of LHC Group in the 3rd quarter valued at about $1,421,000. Great West Life Assurance Co. Can boosted its position in shares of LHC Group by 3.7% in the 2nd quarter. Great West Life Assurance Co. Can now owns 22,229 shares of the health services provider’s stock valued at $1,508,000 after purchasing an additional 790 shares during the period. Finally, Linscomb & Williams Inc. acquired a new stake in shares of LHC Group in the 2nd quarter valued at about $2,268,000. 85.51% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.com-unik.info/2017/12/05/valuengine-downgrades-lhc-group-lhcg-to-hold.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

What are top analysts saying about LHC Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LHC Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit